ReviewFrontiers in pharmacology2026
The modern scientific interpretation of ancient wisdom: a review of the phytochemistry and pharmacology of Erzhi Pill and its constituent botanical drugs.
Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Erzhi Pill has been used in traditional Chinese medicine for nearly six centuries. It concurrently delivers nourishing Liver-Kidney Yin (lower) and clears floating deficiency fire (upper) to holistically tackle both the root cause and symptoms of disorders including osteoporosis and menopausal syndrome. Thus, Erzhi Pill has an established reputation as the primary formula for "clearing the upper and tonifying the lower." While modern clinical and experimental evidence has demonstrated the therapeutic potential of Erzhi Pill, its further development is impeded by several challenges, including simplistic quality control markers, unclear pharmacological mechanisms, and imprecise clinical indications. To support the quality standardization and enhanced clinical use of Erzhi Pill, this review systematically evaluates its constituent botanical drugs and final formula across multiple domains, including the resource distribution of its metabolite constituent botanical drugs, phytochemical profiles, efficacy, mechanisms, and applications, thereby establishing a foundation for further development of Erzhi Pill. Furthermore, we summarized future research directions of Erzhi Pill, which may include exploring integrated quality control markers and pharmacodynamic substances, adopting synchronized screening strategies for active ingredients and targets to elucidate the target network, and clarifying indications and precise medication strategies through evidence-based medical methodologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.